ALGN vs DNTH · P/E 35, rev $2.10B vs rev $17.8M
Align Technology Inc (ALGN) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported DNTH revenue for 2026-06-30 was $17.8M. Net income was -$91.0M. DNTH currently screens at market cap $4.40B.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the ALGN and DNTH stock pages for the full models.
Not investment advice.